Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Amalio Telenti is active.

Publication


Featured researches published by Amalio Telenti.


Antimicrobial Agents and Chemotherapy | 2000

Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons : Implications for rapid susceptibility testing

Amy S. Piatek; Amalio Telenti; Megan R. Murray; Hiyam H. El-Hajj; William R. Jacobs; Fred Russell Kramer; David Alland

ABSTRACT Past genotypic studies of Mycobacterium tuberculosismay have incorrectly estimated the importance of specific drug resistance mutations due to a number of sampling biases including an overrepresentation of multidrug-resistant (MDR) isolates. An accurate assessment of resistance mutations is crucial for understanding basic resistance mechanisms and designing genotypic drug resistance assays. We developed a rapid closed-tube PCR assay using fluorogenic reporter molecules called molecular beacons to detect reportedly common M. tuberculosis mutations associated with resistance to isoniazid and rifampin. The assay was used in a comparative genotypic investigation of two different study populations to determine whether these known mutations account for most cases of clinical drug resistance. We analyzed samples from a reference laboratory in Madrid, Spain, which receives an overrepresentation of MDR isolates similar to prior studies and from a community medical center in New York where almost all of the resistant isolates and an equal number of susceptible controls were available. The ability of the molecular beacon assay to predict resistance to isoniazid and rifampin was also assessed. The overall sensitivity and specificity of the assay for isoniazid resistance were 85 and 100%, respectively, and those for rifampin resistance were 98 and 100%, respectively. Rifampin resistance mutations were detected equally well in isolates from both study populations; however, isoniazid resistance mutations were detected in 94% of the isolates from Madrid but in only 76% of the isolates from New York (P = 0.02). In New York, isoniazid resistance mutations were significantly more common in the MDR isolates (94%) than in single-drug-resistant isolates (44%; P < 0.001). No association between previously described mutations in thekasA gene and isoniazid resistance was found. The first mutations that cause isoniazid resistance may often occur in sequences that have not been commonly associated with isoniazid resistance, possibly in other as yet uncharacterized genes. The molecular beacon assay was simple, rapid, and highly sensitive for the detection of rifampin-resistant M. tuberculosis isolates and for the detection of isoniazid resistance in MDR isolates.


Microbiology | 1998

Inteins in mycobacterial GyrA are a taxonomic character

Peter Sander; Fernando Alcaide; Ingeborg Richter; Klaus Frischkorn; Enrico Tortoli; Burkhard Springer; Amalio Telenti; Erik C. Böttger

The A subunit of DNA gyrase in mycobacteria is frequently subjected to splicing events as its gene, gyrA, harbours an insertion encoding an intein. Investigation of a number of different isolates of Mycobacterium kansasii, Mycobacterium malmoense, Mycobacterium marinum, Mycobacterium ulcerans and Mycobacterium xenopi demonstrated that the presence of GyrA inteins is not random but a taxonomic character specific for a given taxon at a species or subspecies level.


Digestive Surgery | 1996

Time Frame for Infectious Complications in the Surgical-Trauma Intensive-Care Unit

Amalio Telenti

Fever is a frequent diagnostic dilemma in the intensive-care unit (ICU), and a definitive diagnosis of infection may be established in less than 10-15 % of patients. This uncertainty results in excessive use of empirical antibiotics and unnecessary diagnostic investigations. The diagnostic approach can benefit from the careful description of various ICU time periods characterized by different infection rates and a restricted number of ICU-related infectious complications. Incorporation of the concept of ‘infection time frame’ may allow a better targeting of populations at risk.


Journal of Microbiological Methods | 1995

Nucleic acid amplification methods in diagnostic virology

Daniel Germann; Amalio Telenti

The speed, sensitivity and specificity of nucleic acid amplification techniques make them very attractive tools for diagnostic virology. Priorities should be defined for the stepwise implementation of these methods. Their application is not limited to the purpose of direct diagnosis, but includes quantitation of viral load, evaluation of genetic determinants of resistance to antiviral drugs, typing of strains, and the analysis of new viral pathogens. However, a widespread use of these techniques by clinical laboratories will require fully standardized, carefully controlled systems. Very few commercial systems are as yet available.


Digestive Surgery | 1996

Appendicitis: Spectrum of Bacteria and the Role of Antimicrobial Therapy

Amalio Telenti

The use of perioperative antibiotics has been shown to decrease infectious complications after appendectomy. Controversy remains as to the optimal antibiotic combination and duration of therapy. Most


Nature Biotechnology | 1998

Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis.

Amy S. Piatek; Sanjay Tyagi; Arno C. Pol; Amalio Telenti; Lincoln P. Miller; Fred Russell Kramer; David Alland


Journal of Clinical Microbiology | 1995

A novel insertion element from Mycobacterium avium, IS1245, is a specific target for analysis of strain relatedness.

C Guerrero; C Bernasconi; D Burki; T Bodmer; Amalio Telenti


Antimicrobial Agents and Chemotherapy | 1997

Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations.

Srinand Sreevatsan; Kathryn E. Stockbauer; Xi Pan; Barry N. Kreiswirth; Soraya L. Moghazeh; William R. Jacobs; Amalio Telenti; James M. Musser


Journal of Clinical Microbiology | 1996

Isolation and characterization of a unique group of slowly growing mycobacteria: description of Mycobacterium lentiflavum sp. nov.

Burkhard Springer; Whei-Kuo Wu; Thomas Bodmer; Gerhard Haase; Gaby E. Pfyffer; Reiner M. Kroppenstedt; Karl-Heinz Schröder; Stefan Emler; James O. Kilburn; Philip Kirschner; Amalio Telenti; Marie B. Coyle; Erik C. Böttger


Antimicrobial Agents and Chemotherapy | 1997

Role of embB in natural and acquired resistance to ethambutol in mycobacteria.

Fernando Alcaide; Gaby E. Pfyffer; Amalio Telenti

Collaboration


Dive into the Amalio Telenti's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Enrico Tortoli

Vita-Salute San Raffaele University

View shared research outputs
Top Co-Authors

Avatar

Amy S. Piatek

Public Health Research Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fred Russell Kramer

Public Health Research Institute

View shared research outputs
Top Co-Authors

Avatar

William R. Jacobs

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge